CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increase in development of the exoskeleton technology by company & organisations
collaborations
4.1.2. Increasing number of people with physical disabilities are creating demand for
effective rehabilitation approaches
4.1.3. Increasing insurance coverage for medical exoskeletons in several countries
4.1.4. Introduction of soft actuators
4.2. Market Restraints & Challenges
4.2.1. High costs of the exoskeleton devices restraints the adoption of home use
4.2.2. Lack of reimbursements
CHAPTER 5. GLOBAL MEDICAL EXOSKELETON MARKET – BY COMPONENT
5.1. Hardware
5.1.1. Sensors
5.1.2. Actuators
5.1.3. Power Sources
5.1.4. Control Systems
5.1.5. Other Hardware Components
5.2. Software
5.3. Others
CHAPTER 6. GLOBAL MEDICAL EXOSKELETON MARKET – BY TYPE
6.1. Powered Exoskeleton
6.2. Passive Exoskeleton
CHAPTER 7. GLOBAL MEDICAL EXOSKELETON MARKET – BY MOBILITY
7.1. Stationary Medical Exoskeletons
7.2. Mobile Medical Exoskeletons
CHAPTER 8. GLOBAL MEDICAL EXOSKELETON MARKET - BY EXTREMITY
8.1. Lower Extremity Medical Exoskeletons
8.2. Upper Extremity Medical Exoskeletons
CHAPTER 9. GLOBAL MEDICAL EXOSKELETON MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
8.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL MEDICAL EXOSKELETON MARKET - COMPANY
PROFILES
10.1. Cyberdyne Inc.
10.2. Ekso Bionics Holdings
10.3. Rewalk Robotics
10.4. Bionik Laboratories Corp.
10.5. Exoatlet O.O.O.
10.6. Parker Hannifin Corporation
10.7. B-Temia Inc.
10.8. Bioness Inc.
10.9. Hocoma AG
10.10. Wearable Robotics
10.11. Gogoa Mobility Robots
CHAPTER 11. GLOBAL MEDICAL EXOSKELETON MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
